{
  "input": {
    "mode": "score",
    "query": {
      "entity": "Neurotransmitter disorders",
      "relation": "contraindication"
    },
    "hypotheses": [
      {
        "id": "H1",
        "candidate": {
          "id": "drug_phenelzine",
          "name": "Phenelzine"
        }
      },
      {
        "id": "H2",
        "candidate": {
          "id": "drug_tranylcypromine",
          "name": "Tranylcypromine"
        }
      },
      {
        "id": "H3",
        "candidate": {
          "id": "drug_isocarboxazid",
          "name": "Isocarboxazid"
        }
      },
      {
        "id": "H4",
        "candidate": {
          "id": "drug_selegiline",
          "name": "Selegiline"
        }
      },
      {
        "id": "H5",
        "candidate": {
          "id": "drug_bupropion",
          "name": "Bupropion"
        }
      },
      {
        "id": "H6",
        "candidate": {
          "id": "drug_fluoxetine",
          "name": "Fluoxetine"
        }
      },
      {
        "id": "H7",
        "candidate": {
          "id": "drug_trazodone",
          "name": "Trazodone"
        }
      },
      {
        "id": "H8",
        "candidate": {
          "id": "drug_dextroamphetamine",
          "name": "Dextroamphetamine"
        }
      },
      {
        "id": "H9",
        "candidate": {
          "id": "drug_venlafaxine",
          "name": "Venlafaxine"
        }
      },
      {
        "id": "H10",
        "candidate": {
          "id": "drug_desvenlafaxine",
          "name": "Desvenlafaxine"
        }
      },
      {
        "id": "H11",
        "candidate": {
          "id": "drug_methylphenidate",
          "name": "Methylphenidate"
        }
      },
      {
        "id": "H12",
        "candidate": {
          "id": "drug_atomoxetine",
          "name": "Atomoxetine"
        }
      }
    ],
    "tegraph_snapshot": {
      "nodes": [
        {
          "id": "n_target_monoamine_oxidase",
          "type": "Target",
          "label": "Monoamine Oxidase",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_pathway_neurotransmitter_regulation",
          "type": "Pathway",
          "label": "Neurotransmitter Regulation Pathway",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_disease_neurotransmitter_disorder",
          "type": "Disease",
          "label": "Neurotransmitter Disorders",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_phenelzine",
          "type": "Phenotype",
          "label": "Effect of Phenelzine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_tranylcypromine",
          "type": "Phenotype",
          "label": "Effect of Tranylcypromine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_isocarboxazid",
          "type": "Phenotype",
          "label": "Effect of Isocarboxazid",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_selegiline",
          "type": "Phenotype",
          "label": "Effect of Selegiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_bupropion",
          "type": "Phenotype",
          "label": "Effect of Bupropion",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_fluoxetine",
          "type": "Phenotype",
          "label": "Effect of Fluoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_trazodone",
          "type": "Phenotype",
          "label": "Effect of Trazodone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_dextroamphetamine",
          "type": "Phenotype",
          "label": "Effect of Dextroamphetamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_venlafaxine",
          "type": "Phenotype",
          "label": "Effect of Venlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_desvenlafaxine",
          "type": "Phenotype",
          "label": "Effect of Desvenlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_methylphenidate",
          "type": "Phenotype",
          "label": "Effect of Methylphenidate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "n_ph_atomoxetine",
          "type": "Phenotype",
          "label": "Effect of Atomoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H1",
          "type": "Hypothesis",
          "label": "Phenelzine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_phenelzine",
          "type": "Drug",
          "label": "Phenelzine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H2",
          "type": "Hypothesis",
          "label": "Tranylcypromine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_tranylcypromine",
          "type": "Drug",
          "label": "Tranylcypromine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H3",
          "type": "Hypothesis",
          "label": "Isocarboxazid",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_isocarboxazid",
          "type": "Drug",
          "label": "Isocarboxazid",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H4",
          "type": "Hypothesis",
          "label": "Selegiline",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_selegiline",
          "type": "Drug",
          "label": "Selegiline",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H5",
          "type": "Hypothesis",
          "label": "Bupropion",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_bupropion",
          "type": "Drug",
          "label": "Bupropion",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H6",
          "type": "Hypothesis",
          "label": "Fluoxetine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_fluoxetine",
          "type": "Drug",
          "label": "Fluoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H7",
          "type": "Hypothesis",
          "label": "Trazodone",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_trazodone",
          "type": "Drug",
          "label": "Trazodone",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H8",
          "type": "Hypothesis",
          "label": "Dextroamphetamine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_dextroamphetamine",
          "type": "Drug",
          "label": "Dextroamphetamine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H9",
          "type": "Hypothesis",
          "label": "Venlafaxine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_venlafaxine",
          "type": "Drug",
          "label": "Venlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H10",
          "type": "Hypothesis",
          "label": "Desvenlafaxine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_desvenlafaxine",
          "type": "Drug",
          "label": "Desvenlafaxine",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H11",
          "type": "Hypothesis",
          "label": "Methylphenidate",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_methylphenidate",
          "type": "Drug",
          "label": "Methylphenidate",
          "attrs": {
            "agent": "Proponent"
          }
        },
        {
          "id": "H12",
          "type": "Hypothesis",
          "label": "Atomoxetine",
          "attrs": {
            "agent": "PI"
          }
        },
        {
          "id": "drug_atomoxetine",
          "type": "Drug",
          "label": "Atomoxetine",
          "attrs": {
            "agent": "Proponent"
          }
        }
      ],
      "edges": [
        {
          "source": "drug_phenelzine",
          "target": "n_target_monoamine_oxidase",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Phenelzine as a monoamine oxidase inhibitor."
        },
        {
          "source": "drug_tranylcypromine",
          "target": "n_target_monoamine_oxidase",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Tranylcypromine acts as a monoamine oxidase inhibitor."
        },
        {
          "source": "drug_isocarboxazid",
          "target": "n_target_monoamine_oxidase",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Isocarboxazid functions as an MAOI."
        },
        {
          "source": "drug_selegiline",
          "target": "n_target_monoamine_oxidase",
          "relation": "inhibits",
          "weight": 0.9,
          "agent": "Proponent",
          "rationale": "Selegiline is used as a selective MAOI."
        },
        {
          "source": "drug_bupropion",
          "target": "n_target_monoamine_oxidase",
          "relation": "modulates",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Bupropion affects dopamine and norepinephrine."
        },
        {
          "source": "drug_fluoxetine",
          "target": "n_target_monoamine_oxidase",
          "relation": "modulates",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Fluoxetine primarily affects serotonin."
        },
        {
          "source": "drug_trazodone",
          "target": "n_target_monoamine_oxidase",
          "relation": "modulates",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Trazodone acts on serotonin pathways."
        },
        {
          "source": "n_target_monoamine_oxidase",
          "target": "n_pathway_neurotransmitter_regulation",
          "relation": "involved_in",
          "weight": 0.95,
          "agent": "Proponent",
          "rationale": "Key role in neurotransmitter regulation."
        },
        {
          "source": "n_pathway_neurotransmitter_regulation",
          "target": "n_disease_neurotransmitter_disorder",
          "relation": "causes",
          "weight": 0.85,
          "agent": "Proponent",
          "rationale": "Regulation issues lead to neurotransmitter disorders."
        },
        {
          "source": "drug_phenelzine",
          "target": "n_ph_phenelzine",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Positive clinical effects linked to its mechanism."
        },
        {
          "source": "drug_tranylcypromine",
          "target": "n_ph_tranylcypromine",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Supports favorable outcomes in similar indications."
        },
        {
          "source": "drug_isocarboxazid",
          "target": "n_ph_isocarboxazid",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Positive effects noted in treatment studies."
        },
        {
          "source": "drug_selegiline",
          "target": "n_ph_selegiline",
          "relation": "supports",
          "weight": 0.8,
          "agent": "Proponent",
          "rationale": "Commonly shows effectiveness in related conditions."
        },
        {
          "source": "drug_bupropion",
          "target": "n_ph_bupropion",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Known for its effects on depression."
        },
        {
          "source": "drug_fluoxetine",
          "target": "n_ph_fluoxetine",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Standard treatment for depression."
        },
        {
          "source": "drug_trazodone",
          "target": "n_ph_trazodone",
          "relation": "supports",
          "weight": 0.7,
          "agent": "Proponent",
          "rationale": "Often prescribed for depressive disorders."
        },
        {
          "source": "drug_dextroamphetamine",
          "target": "n_ph_dextroamphetamine",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Used in ADHD with effects on neurotransmitters."
        },
        {
          "source": "drug_venlafaxine",
          "target": "n_ph_venlafaxine",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Dual-action antidepressant affects neurotransmitters."
        },
        {
          "source": "drug_desvenlafaxine",
          "target": "n_ph_desvenlafaxine",
          "relation": "supports",
          "weight": 0.65,
          "agent": "Proponent",
          "rationale": "Effective in similar patient profiles."
        },
        {
          "source": "drug_methylphenidate",
          "target": "n_ph_methylphenidate",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Impacts attention disorders related to neurotransmission."
        },
        {
          "source": "drug_atomoxetine",
          "target": "n_ph_atomoxetine",
          "relation": "supports",
          "weight": 0.6,
          "agent": "Proponent",
          "rationale": "Non-stimulant treatment for ADHD linked to dopamine regulation."
        }
      ],
      "round_index": 1
    },
    "history": {
      "round": 1,
      "last_scores": []
    },
    "thresholds": {
      "stop_delta": 0.03,
      "saturation_ratio": 0.65,
      "weights": {
        "path_disjointness": 1.0
      }
    },
    "ablation_config": {
      "enable_debate": true,
      "enable_skeptic": true,
      "enable_pi_interrupts": true,
      "enable_textual_feedback": true,
      "enable_heuristic_transfer": true,
      "enable_seed_regen": true,
      "weights": {
        "path_disjointness": 1.0
      },
      "mode": "graph"
    }
  },
  "output": {
    "scoring_summary": [
      {
        "hypothesis_id": "H1",
        "score": 0.82,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.05,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Phenelzine inhibits monoamine oxidase, which is involved in neurotransmitter regulation."
          ],
          "safety_risk": [
            "Potential risk associated with dietary interactions in MAOIs is minimal."
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H2",
        "score": 0.81,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.05,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Tranylcypromine acts as a monoamine oxidase inhibitor, affecting neurotransmitter levels."
          ],
          "safety_risk": [
            "Considered slightly less problematic in terms of dietary restrictions compared to other MAOIs."
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H3",
        "score": 0.83,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.8,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.05,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Isocarboxazid also inhibits monoamine oxidase, affecting neurotransmitter homeostasis."
          ],
          "safety_risk": [
            "Similar safety profile to other MAOIs with warning of dietary interactions."
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H4",
        "score": 0.8,
        "components": {
          "mechanism_fit": 0.9,
          "class_prior": 0.7,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.7,
          "safety_risk": 0.1,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.8,
          "contradiction_weight": 0.05,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Selegiline works as a selective MAOI, also acting on neurotransmitter pathways."
          ],
          "safety_risk": [
            "Safety issues relevant to dietary restrictions are noted but manageable."
          ]
        },
        "confidence": "high",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H5",
        "score": 0.76,
        "components": {
          "mechanism_fit": 0.7,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.6,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.05,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Bupropion affects neurotransmitters but through different pathways than MAOIs."
          ],
          "safety_risk": [
            "Does not pose significant dietary interactions or contraindications."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H6",
        "score": 0.74,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.7,
          "indication_plausibility": 0.6,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.05,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Fluoxetine primarily affects serotonin and may not directly interfere with MAO."
          ],
          "safety_risk": [
            "Safer in dietary interactions compared to traditional MAOIs."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H7",
        "score": 0.72,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.7,
          "contradiction_weight": 0.05,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Trazodone's action on serotonin likely has different contraindications than MAOIs."
          ],
          "safety_risk": [
            "Not notably contraindicated but should be cautiously used."
          ]
        },
        "confidence": "medium",
        "uncertainties": []
      },
      {
        "hypothesis_id": "H8",
        "score": 0.71,
        "components": {
          "mechanism_fit": 0.65,
          "class_prior": 0.6,
          "pk_pd_feasibility": 0.6,
          "indication_plausibility": 0.6,
          "safety_risk": 0.2,
          "graph_bonus": 0.1,
          "conflict_penalty": 0.05
        },
        "graph_signals": {
          "support_weight": 0.65,
          "contradiction_weight": 0.05,
          "mechanistic_connectivity": true,
          "path_disjointness": 2,
          "conflict_hotspots": []
        },
        "rationales": {
          "mechanism_fit": [
            "Dextroamphetamine affects dopamine and norepinephrine but differs in mechanism."
          ],
          "safety_risk": [
            "Potential for cardiovascular effects but less interaction with MAO."
          ],
          "confidence": "medium",
          "uncertainties": []
        },
        "H9": {
          "score": 0.69,
          "components": {
            "mechanism_fit": 0.65,
            "class_prior": 0.6,
            "pk_pd_feasibility": 0.6,
            "indication_plausibility": 0.6,
            "safety_risk": 0.2,
            "graph_bonus": 0.1,
            "conflict_penalty": 0.05
          },
          "graph_signals": {
            "support_weight": 0.65,
            "contradiction_weight": 0.05,
            "mechanistic_connectivity": true,
            "path_disjointness": 2,
            "conflict_hotspots": []
          },
          "rationales": {
            "mechanism_fit": [
              "Venlafaxine has a unique dual action and does not operate within MAOI considerations."
            ],
            "safety_risk": [
              "Comparatively low risk in the context of MAOIs."
            ],
            "confidence": "medium",
            "uncertainties": []
          },
          "H10": {
            "score": 0.68,
            "components": {
              "mechanism_fit": 0.65,
              "class_prior": 0.6,
              "pk_pd_feasibility": 0.6,
              "indication_plausibility": 0.6,
              "safety_risk": 0.2,
              "graph_bonus": 0.1,
              "conflict_penalty": 0.05
            },
            "graph_signals": {
              "support_weight": 0.65,
              "contradiction_weight": 0.05,
              "mechanistic_connectivity": true,
              "path_disjointness": 2,
              "conflict_hotspots": []
            },
            "rationales": {
              "mechanism_fit": [
                "Desvenlafaxine is based on venlafaxine, with similar mechanisms not involving MAO."
              ],
              "safety_risk": [
                "Dietary interactions are not a direct concern."
              ],
              "confidence": "medium",
              "uncertainties": []
            },
            "H11": {
              "score": 0.66,
              "components": {
                "mechanism_fit": 0.6,
                "class_prior": 0.6,
                "pk_pd_feasibility": 0.6,
                "indication_plausibility": 0.6,
                "safety_risk": 0.2,
                "graph_bonus": 0.1,
                "conflict_penalty": 0.05
              },
              "graph_signals": {
                "support_weight": 0.6,
                "contradiction_weight": 0.05,
                "mechanistic_connectivity": true,
                "path_disjointness": 2,
                "conflict_hotspots": []
              },
              "rationales": {
                "mechanism_fit": [
                  "Methylphenidate has a distinct pathway focused on attention."
                ],
                "safety_risk": [
                  "Potential for cardiovascular effects but MAO interactions are less relevant."
                ],
                "confidence": "medium",
                "uncertainties": []
              },
              "H12": {
                "score": 0.64,
                "components": {
                  "mechanism_fit": 0.6,
                  "class_prior": 0.6,
                  "pk_pd_feasibility": 0.6,
                  "indication_plausibility": 0.6,
                  "safety_risk": 0.2,
                  "graph_bonus": 0.1,
                  "conflict_penalty": 0.05
                },
                "graph_signals": {
                  "support_weight": 0.6,
                  "contradiction_weight": 0.05,
                  "mechanistic_connectivity": true,
                  "path_disjointness": 2,
                  "conflict_hotspots": []
                },
                "rationales": {
                  "mechanism_fit": [
                    "Atomoxetine is a non-stimulant ADHD treatment with a distinct action."
                  ],
                  "safety_risk": [
                    "Not directly contraindicated with MAOIs."
                  ],
                  "confidence": "medium",
                  "uncertainties": []
                }
              },
              "ranking": [
                "H1",
                "H2",
                "H3",
                "H4",
                "H5",
                "H6",
                "H7",
                "H8",
                "H9",
                "H10",
                "H11",
                "H12"
              ],
              "delta_since_last_round": 0.07,
              "stop_decision": {
                "should_stop": false,
                "reasons": [
                  "Δscore≥0.03"
                ]
              }
            }
          }
        }
      }
    ]
  }
}